Hikma Pharmaceutical reported 22M in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
argenx SE 1.13M 9K Jun/2025
AstraZeneca 303M 126M Jun/2025
Autolus Therapeutics Ltd -6830000 16.97M Jun/2025
Bayer 495M 89M Jun/2025
Fresenius 86M 30M Jun/2025
Galapagos EUR 780K 49.34M Mar/2025
Genmab DKK 9M 4M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Lonza CHF 70M 11M Dec/2024
Merck 79M 1000K Jun/2025
Orion 1.2M 200K Jun/2025
Recordati EUR 24.49M 6.41M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
UCB 108M 16M Dec/2024